A detailed history of General American Investors CO Inc transactions in Valneva Se stock. As of the latest transaction made, General American Investors CO Inc holds 354,361 shares of VALN stock, worth $1.41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
354,361
Previous 354,361 -0.0%
Holding current value
$1.41 Million
Previous $2.48 Million 13.85%
% of portfolio
0.15%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$6.64 - $10.76 $62,157 - $100,724
9,361 Added 2.71%
354,361 $2.81 Million
Q4 2022

Feb 10, 2023

SELL
$10.38 - $14.87 $311,400 - $446,100
-30,000 Reduced 8.0%
345,000 $4.39 Million
Q3 2022

Oct 31, 2022

BUY
$9.8 - $23.35 $3.68 Million - $8.76 Million
375,000 New
375,000 $3.77 Million
Q3 2021

Nov 01, 2021

SELL
$25.02 - $53.38 $1.88 Million - $4 Million
-75,000 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$24.41 - $31.04 $1.83 Million - $2.33 Million
75,000 New
75,000 $1.98 Million

Others Institutions Holding VALN

About Valneva SE


  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $276M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track General American Investors CO Inc Portfolio

Follow General American Investors CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.